Barclays Plc - Apr 25, 2022 Form 3 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
10%+ Owner
Signature
Suejean Mott
Stock symbol
PYXS
Transactions as of
Apr 25, 2022
Transactions value $
$0
Form type
3
Date filed
4/26/2022, 01:40 PM
Previous filing
Mar 9, 2022
Next filing
Apr 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PYXS Common Stock, par value $0.001 per share 3.48M Apr 25, 2022 By Barclays Bank PLC
holding PYXS Common Stock, par value $0.001 per share 30 Apr 25, 2022 By Barclays Capital Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

(a) Beneficially owned Class A ordinary shares are comprised in Units, each consisting of one class A ordinary share (b) Name of Person Filing: (1) Barclays PLC (2) Barclays Bank PLC (controlled by Barclays PLC) (3) Barclays Capital Inc. (controlled by Barclays PLC) (c) Address of Principal Business Office or, if none, Residence: (1) Barclays PLC 1 Churchill Place London, E14 5HP, England (2) Barclays Bank PLC 1 Churchill Place London, E14 5HP, England (3) Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 United States